Advisor: Christopher Bradfield, PhD
Keywords: corneal disease, gene therapy, gene editing, monogenic disease, translational research, animal models
Education
BS in Molecular Genetics and Microbiology, The Ohio State University
PhD in Translational Biology and Molecular Medicine, Baylor College of Medicine
Research
Dr. Veith is interested in using genome engineering to generate novel animal models of disease, including those that affect the eye. As a translational researcher, his research focus in the Bradfield Lab is to develop corrective gene therapy approaches for Posterior Polymorphous Corneal Dystrophy type (PPCD)1. PPCD1